Second generation of BACE-1 inhibitors. Part 1: The need for improved pharmacokinetics

被引:45
作者
Charrier, Nicolas [1 ]
Clarke, Brian [1 ]
Cutler, Leanne [1 ]
Demont, Emmanuel [1 ]
Dingwall, Colin [1 ]
Dunsdon, Rachel [1 ]
Hawkins, Julie [1 ]
Howes, Colin [1 ]
Hubbard, Julia [1 ]
Hussain, Ishrut [1 ]
Maile, Graham [1 ]
Matico, Rosalie [1 ]
Mosley, Julie [1 ]
Naylor, Alan [1 ]
O'Brien, Alistair [1 ]
Redshaw, Sally [1 ]
Rowland, Paul [1 ]
Soleil, Virginie [1 ]
Smith, Kathrine J. [1 ]
Sweitzer, Sharon [1 ]
Theobald, Pam [1 ]
Vesey, David [1 ]
Walter, Daryl S. [1 ]
Wayne, Gareth [1 ]
机构
[1] GlaxoSmithKline R&D, Neurol & Gastrointestinal Ctr Excellence Drug Dis, Harlow CM19 5AW, Essex, England
关键词
Alzheimer; BACE-1; Aspartic protease; Hydroxyethylamine; AMYLOID PRECURSOR PROTEIN; BETA-SECRETASE; ALZHEIMERS-DISEASE; IN-VIVO; IDENTIFICATION; PURIFICATION; CLEAVAGE; POTENCY;
D O I
10.1016/j.bmcl.2009.03.165
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
Inhibition of the aspartyl protease BACE-1 has the potential to deliver a disease-modifying therapy for Alzheimer's disease. We have recently disclosed a series of transition-state mimetic BACE-1 inhibitors showing nanomolar potency in cell-based assays. Amongst them, GSK188909 (compound 2) had favorable pharmacokinetics and was the first orally bioavailable inhibitor reported to demonstrate brain amyloid lowering in an animal model. In this Letter, we describe the reasons that led us to favor a second generation of inhibitors for further in vivo studies. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3664 / 3668
页数:5
相关论文
共 12 条
[1]
BACE-1 inhibitors part 3: Identification of hydroxy ethylamines (HEAs) with nanomolar potency in cells [J].
Beswick, Paul ;
Charrier, Nicolas ;
Clarke, Brian ;
Demont, Emmanuel ;
Dingwall, Colin ;
Dunsdon, Rachel ;
Faller, Andrew ;
Gleave, Robert ;
Hawkins, Julie ;
Hussain, Ishrut ;
Johnson, Christopher N. ;
MacPherson, David ;
Maile, Graham ;
Matico, Rosalie ;
Milner, Peter ;
Mosley, Julie ;
Naylor, Alan ;
O'Brien, Alistair ;
Redshaw, Sally ;
Riddell, David ;
Rowland, Paul ;
Skidmore, John ;
Soleil, Virginie ;
Smith, Kathrine J. ;
Stanway, Steven ;
Stemp, Geoffrey ;
Stuart, Alistair ;
Sweitzer, Sharon ;
Theobald, Pam ;
Vesey, David ;
Walter, Daryl S. ;
Ward, John ;
Wayne, Gareth .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (03) :1022-1026
[2]
Second generation of hydroxyethylamine BACE-1 inhibitors: Optimizing potency and oral bioavailability [J].
Charrier, Nicolas ;
Clarke, Brian ;
Cutler, Leanne ;
Demont, Emmanuel ;
Dingwall, Colin ;
Dunsdon, Rachel ;
East, Philip ;
Hawkins, Julie ;
Howes, Colin ;
Hussain, Ishrut ;
Jeffrey, Phil ;
Maile, Graham ;
Matico, Rosalie ;
Mosley, Julie ;
Naylor, Alan ;
O'Brien, Alistair ;
Redshaw, Sally ;
Rowland, Paul ;
Soleil, Virginie ;
Smith, Kathrine J. ;
Sweitzer, Sharon ;
Theobald, Pam ;
Vesey, David ;
Walter, Daryl S. ;
Wayne, Gareth .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (11) :3313-3317
[3]
Drug therapy - Alzheimer's disease [J].
Cummings, JL .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (01) :56-67
[4]
Durham TB, 2006, CURR OPIN DRUG DISC, V9, P776
[5]
ALZHEIMERS-DISEASE - INITIAL REPORT OF THE PURIFICATION AND CHARACTERIZATION OF A NOVEL CEREBROVASCULAR AMYLOID PROTEIN [J].
GLENNER, GG ;
WONG, CW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 120 (03) :885-890
[6]
Identification of a novel aspartic protease (Asp 2) as β-secretase [J].
Hussain, I ;
Powell, D ;
Howlett, DR ;
Tew, DG ;
Week, TD ;
Chapman, C ;
Gloger, IS ;
Murphy, KE ;
Southan, CD ;
Ryan, DM ;
Smith, TS ;
Simmons, DL ;
Walsh, FS ;
Dingwall, C ;
Christie, G .
MOLECULAR AND CELLULAR NEUROSCIENCE, 1999, 14 (06) :419-427
[7]
Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases β-cleavage of amyloid precursor protein and amyloid-β production in vivo [J].
Hussain, Ishrut ;
Hawkins, Julie ;
Harrison, David ;
Hille, Christopher ;
Wayne, Gareth ;
Cutler, Leanne ;
Buck, Tania ;
Walter, Daryl ;
Demont, Emmanuel ;
Howes, Colin ;
Naylor, Alan ;
Jeffrey, Philip ;
Gonzalez, Maria I. ;
Dingwall, Colin ;
Michel, Anton ;
Redshaw, Sally ;
Davis, John B. .
JOURNAL OF NEUROCHEMISTRY, 2007, 100 (03) :802-809
[8]
Macrocyclic peptidomimetic β-secretase (BACE-1) inhibitors with activity in vivo [J].
Machauer, Rainer ;
Laumen, Kurt ;
Veenstra, Siem ;
Rondeau, Jean-Michel ;
Tintelnot-Blomley, Marina ;
Betschart, Claudia ;
Jaton, Anne-Lise ;
Desrayaud, Sandrine ;
Staufenbiel, Matthias ;
Rabe, Sabine ;
Paganetti, Paolo ;
Neumann, Ulf .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (05) :1366-1370
[9]
First Demonstration of Cerebrospinal Fluid and Plasma Aβ Lowering with Oral Administration of a β-Site Amyloid Precursor Protein-Cleaving Enzyme 1 Inhibitor in Nonhuman Primates [J].
Sankaranarayanan, Sethu ;
Holahan, Marie A. ;
Colussi, Dennis ;
Crouthamel, Ming-Chih ;
Devanarayan, Viswanath ;
Ellis, Joan ;
Espeseth, Amy ;
Gates, Adam T. ;
Graham, Samuel L. ;
Gregro, Allison R. ;
Hazuda, Daria ;
Hochman, Jerome H. ;
Holloway, Katharine ;
Jin, Lixia ;
Kahana, Jason ;
Lai, Ming-tain ;
Lineberger, Janet ;
McGaughey, Georgia ;
Moore, Keith P. ;
Nantermet, Philippe ;
Pietrak, Beth ;
Price, Eric A. ;
Rajapakse, Hemaka ;
Stauffer, Shaun ;
Steinbeiser, Melissa A. ;
Seabrook, Guy ;
Selnick, Harold G. ;
Shi, Xiao-Ping ;
Stanton, Matthew G. ;
Swestock, John ;
Tugusheva, Katherine ;
Tyler, Keala X. ;
Vacca, Joseph P. ;
Wong, Jacky ;
Wu, Guoxin ;
Xu, Min ;
Cook, Jacquelynn J. ;
Simon, Adam J. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 328 (01) :131-140
[10]
Purification and cloning of amyloid precursor protein β-secretase from human brain [J].
Sinha, S ;
Anderson, JP ;
Barbour, R ;
Basi, GS ;
Caccavello, R ;
Davis, D ;
Doan, M ;
Dovey, HF ;
Frigon, N ;
Hong, J ;
Jacobson-Croak, K ;
Jewett, N ;
Keim, P ;
Knops, J ;
Lieberburg, I ;
Power, M ;
Tan, H ;
Tatsuno, G ;
Tung, J ;
Schenk, D ;
Seubert, P ;
Suomensaari, SM ;
Wang, SW ;
Walker, D ;
Zhao, J ;
McConlogue, L ;
John, V .
NATURE, 1999, 402 (6761) :537-540